Literature DB >> 26806782

Clinical neuroscience of amphetamine-type stimulants: From basic science to treatment development.

Kelly E Courtney1, Lara A Ray2.   

Abstract

Abuse of amphetamine-type stimulants (ATS) poses a significant public health concern with known neurotoxic and neurocognitive effects to the user. In this chapter, we seek to integrate the latest research on ATS, particularly methamphetamine, by covering areas of pharmacology, neurocognitive effects, and the treatment of ATS use disorders with the goal of advancing the clinical neuroscience of ATS and highlighting avenues for future research.
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATS use disorders; Addiction; Amphetamine; Clinical neuroscience; Methamphetamine; Stimulants; Treatment

Mesh：

Substances：

Year:  2015        PMID： 26806782     DOI： 10.1016/bs.pbr.2015.07.010

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN： 0079-6123            Impact factor:   2.453


  3 in total

1.  Variants in GABBR1 Gene Are Associated with Methamphetamine Dependence and Two Years' Relapse after Drug Rehabilitation.

Authors:  Yan Zhao; Sufang Peng; Haifeng Jiang; Jiang Du; Shunying Yu; Min Zhao
Journal:  J Neuroimmune Pharmacol       Date:  2018-08-24       Impact factor: 4.147

Review 2.  Neuroscience-informed psychoeducation for addiction medicine: A neurocognitive perspective.

Authors:  Hamed Ekhtiari; Tara Rezapour; Robin L Aupperle; Martin P Paulus
Journal:  Prog Brain Res       Date:  2017-10-06       Impact factor: 2.453

3.  Refractory Methamphetamine-Induced Psychosis: An Emerging Crisis in Rural America and the Role of Amantadine in Therapeutics.

Authors:  Mayank Gupta; Nihit Gupta; Michael Esang; Angelica Antai; Jeffrey Moll
Journal:  Cureus       Date:  2022-03-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.